Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban versus vitamin K antagonist during atrial fibrillation ablation
ISRCTN87711003Phase 4Completed
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of apixaban in Atrial fibrillation (AFib) (2 arms), sponsored by Kompetenznetz Vorhofflimmern. Primary endpoint: Composite of all-cause death, stroke, or major bleeding. Started Jan 2015; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ISRCTN87711003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87711003.